The U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years. These trial research grants, awarded through the Congressionally-funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases.

“Now, more than ever, we see the important role of these…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.